🔗 Share this article Individuals Coming Off Weight-Loss Jabs Regain Pounds Far More Rapidly Compared to Those on Conventional Diets Obesity treatment involves ongoing approaches. Fresh analysis indicates that individuals who discontinue popular weight-loss injections like Wegovy and Mounjaro tend to recover reduced body mass much more quickly than those who stop traditional diet and exercise regimens. Published data in a leading medical journal demonstrates that while overweight people can lose substantial amounts of their total mass while undergoing treatment, the weight is regained at an average rate of nearly a kilo each month after stopping. "Users buying such drugs should be cognizant of the risk of quick rebound weight gain when the therapy is stopped," stated researcher Dr. Susan Jebb. That rate of recovery suggests a reversion to starting weight in about 18 months. Weighing Treatments The study, which reviewed 37 of trials involving over 9,000 of participants, compared the results of the injectable medications with conventional dieting. The team emphasize that people who lose weight through dieting usually have a slower weight regain—approximately 0.1 kg a month—once they finish. The Reason for the Quick Rebound Experts propose the mode of action of the jabs is key to understanding the accelerated weight return. These medications mimic a body's own chemical called GLP-1, which helps regulate hunger. "Artificially providing the hormone concentrations far above than normal may cause the body to produce less of its endogenous GLP-1, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition researcher. "Stopping of this medication leads to appetite is unsuppressed, making overeating far more likely." A Lifelong Condition? The NHS suggest the injections for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications. A number of clinicians contend that, given the likelihood of relapse, the treatment should be considered long-term. This opinion is reinforced by drug manufacturers, who note that the findings "highlight the chronic nature of excess weight," akin to managing conditions like high blood pressure. Patient Accounts Individuals who have discontinued the jabs describe a sudden resurgence of appetite. "It felt as if a switch that goes on and you're instantly extremely hungry," recalled a patient. The struggle is exacerbated if patients have not adopted permanent lifestyle or habit modifications during treatment. Significant Interest Survey data show that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow. Use is higher among females compared to males. The 40s and 50s demographic shows the greatest level of interest. A large proportion obtain the medications through private prescriptions rather than public health services. In conclusion, experts caution that while GLP-1 drugs are powerful tools for weight loss, they are not a magic solution and maintained weight loss likely depends on ongoing lifestyle changes.
Obesity treatment involves ongoing approaches. Fresh analysis indicates that individuals who discontinue popular weight-loss injections like Wegovy and Mounjaro tend to recover reduced body mass much more quickly than those who stop traditional diet and exercise regimens. Published data in a leading medical journal demonstrates that while overweight people can lose substantial amounts of their total mass while undergoing treatment, the weight is regained at an average rate of nearly a kilo each month after stopping. "Users buying such drugs should be cognizant of the risk of quick rebound weight gain when the therapy is stopped," stated researcher Dr. Susan Jebb. That rate of recovery suggests a reversion to starting weight in about 18 months. Weighing Treatments The study, which reviewed 37 of trials involving over 9,000 of participants, compared the results of the injectable medications with conventional dieting. The team emphasize that people who lose weight through dieting usually have a slower weight regain—approximately 0.1 kg a month—once they finish. The Reason for the Quick Rebound Experts propose the mode of action of the jabs is key to understanding the accelerated weight return. These medications mimic a body's own chemical called GLP-1, which helps regulate hunger. "Artificially providing the hormone concentrations far above than normal may cause the body to produce less of its endogenous GLP-1, and may also diminish responsiveness to its actions," said Dr. Adam Collins, a nutrition researcher. "Stopping of this medication leads to appetite is unsuppressed, making overeating far more likely." A Lifelong Condition? The NHS suggest the injections for individuals with obesity-related health risks, accompanied by recommended diet and exercise modifications. A number of clinicians contend that, given the likelihood of relapse, the treatment should be considered long-term. This opinion is reinforced by drug manufacturers, who note that the findings "highlight the chronic nature of excess weight," akin to managing conditions like high blood pressure. Patient Accounts Individuals who have discontinued the jabs describe a sudden resurgence of appetite. "It felt as if a switch that goes on and you're instantly extremely hungry," recalled a patient. The struggle is exacerbated if patients have not adopted permanent lifestyle or habit modifications during treatment. Significant Interest Survey data show that a significant number of people in the UK have used weight-loss jabs in the last 12 months, with desire continuing to grow. Use is higher among females compared to males. The 40s and 50s demographic shows the greatest level of interest. A large proportion obtain the medications through private prescriptions rather than public health services. In conclusion, experts caution that while GLP-1 drugs are powerful tools for weight loss, they are not a magic solution and maintained weight loss likely depends on ongoing lifestyle changes.